Completed PHASE3 INTERVENTIONAL 2-arm NCT01455870

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Sitagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes

Sponsor: Intarcia Therapeutics

Conditions Type 2 Diabetes

Interventions ITCA 650 60 mcg/day sitagliptin

Updated 8 times since 2017 Last updated: May 13, 2016 Started: May 31, 2013 Primary completion: Jul 31, 2015 Completion: Jul 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Type 2 Diabetes and is currently completed. Intarcia Therapeutics leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Apr 2022 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Apr 2022 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Intarcia Therapeutics

Data source: Intarcia Therapeutics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Avon, United States , Bad Lauterberg im Harz, Germany , Bend, United States , Billings, United States , Birmingham, United States , Boca Raton, United States , Brockton, United States , Brooklyn, United States , Canton, United States , Chandler, United States and 41 more locations